Published in Medical Letter on the CDC and FDA, September 9th, 2007
"We are pleased that the NIAID scientific review board has found significant merit in our HIV vaccine development program," said Dr. Frank Jones, Chairman and Chief Executive Officer of Etubics. "The award enables Etubics to extend its Vironix-HIV-gag vaccine platform to other HIV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.